29
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Animal Models of Amphetamine Psychosis: Neurotransmitter Release from Rat Brain Slices

, , &
Pages 1-15 | Received 04 Mar 1991, Published online: 07 Jul 2009
 

Abstract

As animal models of psychosis, adult rats were exposed to different types of treatment with amphetamine: (1) subcutaneous implantation with osmotic minipumps or (2) daily intraperitoneal injections for 7 days and (3) one single amphetamine injection. Continuous administration caused tolerance, intermittent injections sensitization and the acute injection a behavioral arousal with stereotypes. All amphetamine treatments diminished the potassium-stimulated (50 mM) release of preloaded labelled dopamine from supervised striatal and frontal cortical slices in vitro. Only acute amphetamine enhanced the release of D-aspartate, an analogue of L-glutamate from frontal cortical slices. The results indicate that amphetamine profoundly affects the brain dopaminergic systems but less the glutamatergic systems. Amphetamine systematically enhanced the release of γ-aminobutyrate (GABA) from striatal slices, but otherwise the GABAergic systems seem to be more sensitive to handling stress than to the administration of amphetamine. Besides dopaminergic mechanisms other interacting systems must thus be taken into account to explain behavioral responses to amphetamine.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.